Status:
COMPLETED
Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins
Lead Sponsor:
University of Massachusetts, Worcester
Conditions:
Multiple System Atrophy
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Multiple System Atrophy (MSA) is a progressive sporadic neurodegenerative disorder leading to widespread loss of brain cells that results in parkinsonian, cerebellar and autonomic dysfunction. The cau...
Eligibility Criteria
Inclusion
- Male or female older than 17 years.
- Clinical diagnosis of probable multiple system atrophy
- Provide written informed consent to participate in the study
- Understand that they may withdraw their consent at any time
Exclusion
- Women who are pregnant or lactating
- In the investigator's opinion, have any other significant systemic, hepatic, cardiac or renal illness.
- In the investigator's opinion, the subjects are significantly dehydrated, as determined by clinical evaluation including measurement of skin turgor, blood urea nitrogen and creatinine values.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00750867
Start Date
June 1 2008
End Date
December 1 2012
Last Update
February 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Massachusetts Medical School
Worcester, Massachusetts, United States, 01655